Gruber James R. — SEC Form 4 filings

SEC reporting owner CIK 1923165. 5 Form 4 filings on record with FilingPulse; latest filed 2026-01-14.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-02-15 to 2026-01-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Eton Pharmaceuticals, Inc. (ETON)Chief Financial Officer52 legs · 41,713 sh · $673,7148

Form 4 filings — Gruber James R.

FiledFormIssuerReported transactionsSource
2026-01-144Eton Pharmaceuticals, Inc. (ETON)Tax withholding (F): 2,293 @ $15.47 · Grant/award (A): 40,655 (derivative) @ $0 · Grant/award (A): 25,856 (derivative) @ $0EDGAR
2025-12-124Eton Pharmaceuticals, Inc. (ETON)Tax withholding (F): 4,542 @ $16.99 · Grant/award (A): 5,502 (derivative) @ $0EDGAR
2025-08-204Eton Pharmaceuticals, Inc. (ETON)Sale (S): 39,082 @ $16.16 · Sale (S): 2,631 @ $16.02EDGAR
2025-01-064Eton Pharmaceuticals, Inc. (ETON)Grant/award (A): 38,621 (derivative) @ $0 · Grant/award (A): 25,876 (derivative) @ $0EDGAR
2024-02-154Eton Pharmaceuticals, Inc. (ETON)Grant/award (A): 144,677 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1923165 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →